3,6 %Microbiological screening as the initial test, followed by culture or Xpert for diagnosis, had 3.6% higher yield than symptom screening followed by microscopy for diagnosis.
Kenyatuberculosepublié 2022Tuberculosis research and treatmenteurope_pmcdocument de 8 observationsDOI 10.1155/2022/9947068
96 %All three tests exhibited negative predictive values greater than 96% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.
Kenyatuberculoseobservé 2022-2023publié 2024PloS onePubMeddocument de 7 observations
0,3 %Amikacin resistance among HIV-negative tuberculosis patients in Western Kenya was 0.3%.
Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations
65 %Overall buccal swab sensitivity was 65.0% versus sputum Xpert and culture.
Kenyatuberculosepublié 2022PloS onePubMeddocument de 10 observations
85 %The Xpert Ultra assay registered a sensitivity of 85.0% for tuberculosis diagnosis among people living with HIV in Nairobi, Kenya.
Kenyatuberculoseobservé 2022-2023publié 2024PloS onePubMeddocument de 7 observations
62,5 %62.5% of caregivers sought care only after persistent tuberculosis symptoms in Gem Sub County, Siaya County, Kenya.
Kenyatuberculosepublié 2026PloS onePubMeddocument de 9 observations
19,7 %Serological evidence of chronic pulmonary aspergillosis (CPA) or fungal sensitization was found in 46 out of 234 PTB patients in Kenya, representing 19.7%.
Kenyapulmonary aspergillosis · tuberculosepublié 2022BMC infectious diseasesPubMeddocument de 14 observations
52 %More than half (52%) of mortality among HIV-positive tuberculosis patients was ascribed to advanced HIV disease.
Kenyatuberculose · VIH/sidapublié 2023African health sciencesPubMeddocument de 6 observations
35 %Tuberculosis was the most common HIV/AIDS-related opportunistic infection, accounting for 35% of cases among patients at Kenyatta National Hospital in Nairobi, Kenya.
Kenyatuberculoseobservé 2010publié 2020African health scienceseurope_pmcdocument de 4 observationsDOI 10.4314/ahs.v20i2.9
4,8 %In 2015, 4.8% of child TB cases in Kenya had an Xpert® test done.
Kenyatuberculoseobservé 2015publié 2018BMC infectious diseaseseurope_pmcdocument de 12 observations
2,1 per_1000_person_yearsThe tuberculosis incidence rate among children living with HIV aged <15 years who completed isoniazid preventive therapy was 2.1 per 1000 person years by 24 months after IPT screening.
Kenyatuberculoseobservé by 24 months after IPT screeningpublié 2022Journal of the International AIDS SocietyPubMeddocument de 7 observations
4 521 patients4521 (70%) of the clinically diagnosed TB patients had a negative sputum/GeneXpert test.
Kenyatuberculoseobservé 2012 to 2018publié 2021Scientific reportsPubMeddocument de 12 observations
0,41 AORChildren had adjusted odds ratio of 0.41 for receiving an Xpert® test compared to adults in Kenya in 2015.
Kenyatuberculoseobservé 2015publié 2018BMC infectious diseaseseurope_pmcdocument de 12 observations
29 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients in Kenya between 2012 and 2015, 29% of women and 20% of men had HIV testing more than 3 months prior to TB treatment.
Kenyatuberculose · VIH/sidaobservé 2012-2015publié 2020PloS onePubMeddocument de 6 observations
In 2010–14, the top causes of death among adolescents aged 12–19 years were road traffic accidents, HIV or tuberculosis, and meningitis or sepsis.
Kenyaméningite (non précisée) · sepsis · tuberculose · VIH/sidaobservé 2010–14publié 2024The Lancet. Global healthPubMeddocument de 6 observations
20 patientsOf the 28 patients who tested positive for tuberculosis (TB) in both SLATE trials, 20 initiated TB treatment.
Kenyatuberculosepublié 2020BMJ openPubMeddocument de 12 observations
38,1 %Among 42 PLHIV who developed active tuberculosis during or after IPT in Kenya between July 2015 and June 2018, 16 (38.1%) developed it during IPT and 26 (61.9%) after completing IPT.
Kenyatuberculose · VIH/sidaobservé July 2015 to June 2018publié 2020PloS onePubMeddocument de 8 observations
4 %Infection with Schistosoma mansoni was associated with a 4% higher estimated proportion of active TB cases in HIV-uninfected individuals.
Kenyatuberculoseobservé 2014 and 2017publié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 2 observations
1 %Among HIV-negative tuberculosis patients in Western Kenya, INH + PZA polyresistant strains occurred in 1% of cases.
Kenyatuberculosepublié 2021BMC infectious diseasesPubMeddocument de 23 observations
90,1 %Among 4708 PLHIV initiated on IPT in Kenya between July 2015 and June 2018, 4,243 (90.1%) had documentation of tuberculosis screening on the IPT tool before IPT initiation.
Kenyatuberculose · VIH/sidaobservé July 2015 to June 2018publié 2020PloS onePubMeddocument de 8 observations
55,3 %Among smear-positive pulmonary tuberculosis/HIV co-infected patients aged 15–49 years in Kenya between 2012 and 2015, 55.3% of men and 50.6% of women had a BMI <18.5.
Kenyatuberculose · VIH/sidaobservé 2012-2015publié 2020PloS onePubMeddocument de 6 observations
1,93 hazard_ratioUnknown HIV status was associated with a 1.93-fold higher hazard of death during TB treatment compared to HIV-negative status.
Kenyatuberculose · VIH/sidaobservé 2012–2020publié 2023BMC infectious diseasesPubMeddocument de 11 observations
27 %Mortality was higher among HIV-positive tuberculosis patients (27%) than among HIV-negative tuberculosis patients (9%).
Kenyatuberculose · VIH/sidapublié 2023African health sciencesPubMeddocument de 6 observations
110 252 casesAnnual TB notifications in Kenya declined from 110,252 in 2008 to 96,562 in 2018.
Kenyatuberculoseobservé 2008publié 2022The international journal of tuberculosis and lung disease : the official journal of the IPubMeddocument de 8 observations
89,2 %GeneXpert sensitivity in non-previously treated people with presumptive TB was 89.2%, compared to 71.1% for ZN microscopy and 73.5% for LED fluorescent microscopy.
Kenyatuberculoseobservé 2013-2014publié 2019African Journal of Health SciencesOpenAlexdocument de 6 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.